One in 20 U.S. adults experience seasonal depression, most often in winter. UVA professor Kim Penberthy shares self-care tips ...

In collaboration with Massachusetts General Hospital as its contract research organization, Alzamend aims to explore the unique properties of AL001 and its effects on lithium delivery in the brain ...

The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...

Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...

CAPLYTA net product sales grew to $199.2 million, representing a 51%increase over the same period in 2023Full year 2024 ...

The following is a summary of “Comparative effectiveness of short-term psychodynamic psychotherapy and cognitive behavioral ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...

The Royal Devon University Healthcare NHS Foundation Trust is leading ground-breaking clinical research that has the potential to transform treatments for neuropsychiatric disorders.

(Won et al., Cell, 2025) Each of these eight conditions also has gene differences that are unique to them individually, so Won and team compared the unique genes with those shared between the ...

For some children and their parents, however, it can be difficult to determine when fears are typical and when they are developing into more serious phobias or anxiety disorders. Fears are a ...